Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
BioXcel Therapeutics, Inc. (BTAI)
USD0.94
-0.09 (-8.74%)
US NASDAQ Healthcare Biotechnology
Address
555 Long Wharf Drive 6511
New Haven, CT, US
New Haven, CT, US
CEO
Vimal D. Mehta
Website
bioxceltherapeutics.com
IPO
2018-03-08
CIK 1720893 ISIN US09075P2048
Description
BioXcel Therapeutics, Inc. is a biopharmaceutical firm that has reached the commercial phase, distinguishing itself by leveraging artificial intelligence to advance the creation of transformative therapies in the fields of neuroscience and immuno-oncology. Their distinctive methodology, termed 'drug re-innovation,' involves harnessing the power of big data and proprietary machine learning algorithms to uncover novel therapeutic applications for existing approved medications or drug candidates with established clinical validation. The company's flagship commercial offering, IGALMI (known during development as BXCL501), is a unique sublingual film delivering dexmedetomidine, designed for the rapid management of agitation experienced by adults with schizophrenia or bipolar I or II disorder. Beyond its current commercial use, BXCL501 is also undergoing further clinical investigation. Studies are underway to assess its efficacy for agitation in individuals with Alzheimer's disease, as an add-on therapy for major depressive disorder, and for use in community settings to address agitation linked to bipolar disorders and schizophrenia. Furthermore, BioXcel is advancing BXCL502, a candidate therapy targeting chronic agitation prevalent in dementia patients. Another key pipeline asset is BXCL701, an orally administered systemic innate immunity activator currently under investigation. This compound shows promise for treating aggressive prostate cancer and advanced solid tumors that have either become resistant to checkpoint inhibitors or have not yet received such treatment. Established in 2017, the company maintains its headquarters in New Haven, Connecticut.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD0.94
-0.09 (-8.74%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
762.1K
Beta
0.32
Float Shares
24.64M
Free Float %
91.0%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.88% | -5.83% | -1.74% | -28.48% | -38.59% | -29.38% | -21.53% | -99.73% | -99.78% | -99.36% | -99.36% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (15 ratings, all time)
Buy
Price Targets & DCF
Current price
0.94
Low
1.00
+6.4%
Consensus
12.00
+1,176.6%
Median
10.00
+963.8%
High
25.00
+2,559.6%
Ratings Trend (MoM)
75% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 3 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 1 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | — | — |
| Last Year | — | — |
| All Time | 5 |
22.60
+2,304.3%
|
Quality scores
Altman Z-Score
-36.74
Distress
Piotroski F-Score
2 / 9
Weak
MOAT Score
1 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
5 / 5
High
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%-71.7% Q1'26: +22.6% (vs Q1'25)
-
EPS growth Biotechnology: +29.7%+75.6% ★ Q1'26: +30.7% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%-11,105.8% Q1'26: -5,732.5% (vs Q1'25)
-
EBIT margin Biotechnology: +0.0%-8,241.9% Q1'26: -4,911.7% (vs Q1'25)
-
ROIC Biotechnology: -16.1%— Q1'26: +180.4% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+381.6% Q1'26: +152.5% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-2.08× Q1'26: -2.49× (vs Q1'25)
Valuation Multiples
From
To
Consensus Estimates
| Metric |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 2 Rev. Ana. 1 EPS Ana. |
Dec 2027 2 Rev. Ana. 2 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
Dec 2029 1 Rev. Ana. 1 EPS Ana. |
Dec 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|
| Revenue |
375.0K
est: 1.18M (-68.2%)
|
1.38M
est: 2.40M (-42.6%)
|
2.27M
est: 2.21M (+2.5%)
|
642.0K
est: 559.4K (+14.8%)
|
1.66M
787.6K – 2.44M
+196.0% YoY
|
18.93M
9.00M – 27.88M
+1,043.3% YoY
|
63.30M
30.11M – 93.20M
+234.3% YoY
|
178.80M
85.04M – 263.26M
+182.5% YoY
|
399.40M
189.96M – 588.06M
+123.4% YoY
|
| EBITDA |
-157.22M
est: -236.2K (-66,465.5%)
|
-165.42M
est: -1.44M (-11,373.2%)
|
-44.16M
est: -1.33M (-3,230.9%)
|
-52.61M
est: -335.6K (-15,576.5%)
|
-993.6K
-1.46M – -472.6K
-196.0% YoY
|
-11.36M
-16.73M – -5.40M
-1,043.3% YoY
|
-37.98M
-55.92M – -18.06M
-234.3% YoY
|
-107.28M
-157.96M – -51.02M
-182.5% YoY
|
-239.64M
-352.84M – -113.97M
-123.4% YoY
|
| EBIT |
-157.54M
est: -236.2K (-66,603.9%)
|
-165.74M
est: -1.44M (-11,395.3%)
|
-44.47M
est: -1.33M (-3,254.2%)
|
-52.91M
est: -335.6K (-15,665.9%)
|
-993.6K
-1.46M – -472.6K
-196.0% YoY
|
-11.36M
-16.73M – -5.40M
-1,043.3% YoY
|
-37.98M
-55.92M – -18.06M
-234.3% YoY
|
-107.28M
-157.96M – -51.02M
-182.5% YoY
|
-239.64M
-352.84M – -113.97M
-123.4% YoY
|
| Net Income |
-165.76M
est: -202.93M (+18.3%)
|
-179.05M
est: -39.19M (-356.9%)
|
-59.60M
est: -302.65M (+80.3%)
|
-69.90M
est: -69.90M (+0.0%)
|
-20.31M
-27.46M – -13.17M
+70.9% YoY
|
-18.72M
-25.46M – -11.98M
+7.8% YoY
|
-9.32M
-15.57M – -3.07M
+50.2% YoY
|
-7.57M
-12.22M – -2.41M
+18.8% YoY
|
18.07M
5.75M – 29.16M
+338.7% YoY
|
| SGA |
68.76M
est: 61.65M (+11.5%)
|
83.41M
est: 140.31M (-40.6%)
|
34.49M
est: 129.02M (-73.3%)
|
20.49M
est: 32.66M (-37.3%)
|
96.69M
45.99M – 142.37M
+196.0% YoY
|
1.11B
525.79M – 1.63B
+1,043.3% YoY
|
3.70B
1.76B – 5.44B
+234.3% YoY
|
10.44B
4.97B – 15.37B
+182.5% YoY
|
23.32B
11.09B – 34.34B
+123.4% YoY
|
| EPS |
-94.67
est: -83.18 (-13.8%)
|
-98.35
est: -3.32 (-2,860.3%)
|
-23.51
est: -24.87 (+5.5%)
|
-5.73
est: -6.51 (+11.9%)
|
-1.67
-2.25 – -1.08
+74.4% YoY
|
-1.53
-2.09 – -0.98
+8.0% YoY
|
-0.79
-1.28 – -0.25
+48.5% YoY
|
-0.62
-1.00 – -0.20
+21.5% YoY
|
1.48
0.47 – 2.39
+338.7% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-18 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-15 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-14 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-61.85M
OE per share TTM
-7.17
Owner's Yield
-232.22%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
261.0%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
5
Total invested
15.9K
Insider transactions (90d)
4
Beneficial owners (>5%)
15
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Vimal Mehta | 9.50M | 32.50% | 955.9K | 8.55M | 955.9K | 8.55M | IN | United States | 2023-09-28 | ↗ |
| 2 | Krishnan Nandabalan | 9.50M | 38.23% | 478.1K | 9.02M | 478.1K | — | IN | United States | 2021-02-16 | ↗ |
| 3 | BioXcel Holdings, Inc. | 9.02M | 37.02% | — | 9.02M | — | — | CO | Delaware | 2021-02-16 | ↗ |
| 4 | BioXcel Holdings, Inc. | 8.55M | 29.20% | — | 8.55M | — | 8.55M | CO | Delaware | 2023-09-28 | ↗ |
| 5 | BioXcel LLC | 8.55M | 29.20% | — | 8.55M | — | 8.55M | OO | Delaware | 2023-09-28 | ↗ |
| 6 | FMR LLC | 1.67M | 10.65% | — | — | 1.67M | — | HC | Delaware | 2018-04-10 | ↗ |
| 7 | Adage Capital Advisors, L.L.C. | 1.55M | 5.53% | — | 1.55M | — | — | OO | Delaware | 2023-02-02 | ↗ |
| 8 | Adage Capital Partners GP, L.L.C. | 1.55M | 5.53% | — | 1.55M | — | — | OO | Delaware | 2023-02-02 | ↗ |
| 9 | Adage Capital Partners, L.P. | 1.55M | 5.53% | — | 1.55M | — | — | PN | Delaware | 2023-02-02 | ↗ |
| 10 | Phillip Gross | 1.55M | 5.53% | — | 1.55M | — | — | IN | United States | 2023-02-02 | ↗ |
| 11 | Robert Atchinson | 1.55M | 5.53% | — | 1.55M | — | — | IN | United States | 2023-02-02 | ↗ |
| 12 | 13-4064930 | 1.51M | 5.40% | 1.46M | — | 1.49M | — | IA | Delaware | 2022-02-14 | ↗ |
| 13 | SSGA FUNDS MANAGEMENT, INC. | 1.47M | 6.03% | — | 1.47M | — | 1.47M | IA | BOSTON, MASSACHUSETTS | 2021-02-11 | ↗ |
| 14 | (1) BlackRock, Inc. | 1.46M | 5.20% | 1.40M | — | 1.46M | — | HC | Delaware | 2023-02-03 | ↗ |
| 15 | STATE STREET CORPORATION | 1.35M | 4.81% | — | 1.32M | — | 1.35M | HC | — | 2022-02-09 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
5
-36 vs prev Q
New positions
0
Closed positions
36
Increased
0
Reduced
2
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | MILLENNIUM MANAGEMENT LLC | 1.84M +807.1K (+78.5%) | 2.94M +304.5K (+11.6%) | 12.93% -0.180 pp | 0.00% +0.000 pp | USD2.14 -25.2% | 2 qtrs — |
| 2 | VANGUARD GROUP INC | 292.8K +100.6K (+52.4%) | 468.4K -23.4K (-4.8%) | 2.06% -0.387 pp | 0.00% +0.000 pp | USD2.20 -27.3% | 4 qtrs — |
| 3 | OAKTREE CAPITAL MANAGEMENT LP | 241.2K +— (+0.0%) | 385.9K -231.5K (-37.5%) | 1.70% -1.376 pp | 0.01% -0.004 pp | USD1.81 -11.6% | 3 qtrs — |
| 4 | GEODE CAPITAL MANAGEMENT, LLC | 206.2K +80.9K (+64.6%) | 329.9K +9.3K (+2.9%) | 1.45% -0.145 pp | 0.00% +0.000 pp | USD2.10 -23.8% | 4 qtrs — |
| 5 | JONES FINANCIAL COMPANIES LLLP | 137.7K +101.7K (+282.5%) | 220.3K +123.1K (+126.7%) | 0.97% +0.511 pp | 0.00% +0.000 pp | USD1.71 -6.4% | 3 qtrs — |
| 6 | JANE STREET GROUP, LLC | 127.5K +127.5K (+100.0%) | 204.0K +204.0K (+100.0%) | 0.90% +0.898 pp | 0.00% +0.000 pp | USD1.60 +0.0% | 1 qtrs NEW |
| 7 | GSA CAPITAL PARTNERS LLP | 120.1K +120.1K (+100.0%) | 192.0K +192.0K (+100.0%) | 0.85% +0.846 pp | 0.02% +0.017 pp | USD1.60 +0.0% | 1 qtrs NEW |
| 8 | FMR LLC | 90.3K -108.3K (-54.5%) | 144.5K -363.9K (-71.6%) | 0.64% -1.896 pp | 0.00% +0.000 pp | USD2.56 -37.5% | 4 qtrs — |
| 9 | BLACKROCK, INC. | 84.4K +114.0 (+0.1%) | 135.0K -80.7K (-37.4%) | 0.59% -0.480 pp | 0.00% +0.000 pp | USD2.45 -34.7% | 4 qtrs — |
| 10 | STATE STREET CORP | 63.2K +10.5K (+19.9%) | 101.1K -33.8K (-25.1%) | 0.45% -0.227 pp | 0.00% +0.000 pp | USD2.40 -33.3% | 2 qtrs — |
| 11 | MAN GROUP PLC | 56.8K +56.8K (+100.0%) | 90.9K +90.9K (+100.0%) | 0.40% +0.400 pp | 0.00% +0.000 pp | USD1.60 +0.0% | 1 qtrs NEW |
| 12 | OAKTREE FUND ADVISORS, LLC | 42.9K +— (+0.0%) | 68.7K -41.2K (-37.5%) | 0.30% -0.245 pp | 0.13% -0.075 pp | USD1.81 -11.6% | 3 qtrs — |
| 13 | HIGHTOWER ADVISORS, LLC | 41.0K +6.0K (+17.1%) | 65.6K -24.0K (-26.8%) | 0.29% -0.157 pp | 0.00% +0.000 pp | USD1.97 -18.8% | 3 qtrs — |
| 14 | NORTHERN TRUST CORP | 38.4K +637.0 (+1.7%) | 61.4K -35.2K (-36.4%) | 0.27% -0.211 pp | 0.00% +0.000 pp | USD2.54 -37.0% | 2 qtrs — |
| 15 | UBS GROUP AG | 38.3K -5.2K (-11.9%) | 61.3K -50.1K (-45.0%) | 0.27% -0.285 pp | 0.00% +0.000 pp | USD2.07 -22.7% | 4 qtrs — |
| 16 | DIVERSIFY WEALTH MANAGEMENT, LLC | 15.0K +— (+0.0%) | 30.8K +2.3K (+7.9%) | 0.11% -0.086 pp | 0.00% 0.000 pp | USD1.81 -11.6% | 3 qtrs — |
| 17 | HRT FINANCIAL LP | 18.1K +18.1K (+100.0%) | 28.0K +28.0K (+100.0%) | 0.13% +0.127 pp | 0.00% +0.000 pp | USD1.60 +0.0% | 1 qtrs NEW |
| 18 | TWO SIGMA SECURITIES, LLC | 17.1K +17.1K (+100.0%) | 27.3K +27.3K (+100.0%) | 0.12% +0.120 pp | 0.00% +0.004 pp | USD1.60 +0.0% | 1 qtrs NEW |
| 19 | ADVISOR GROUP HOLDINGS, INC. | 15.7K +666.0 (+4.4%) | 25.2K -35.9K (-58.7%) | 0.11% -0.081 pp | 0.00% +0.000 pp | USD2.30 -30.4% | 4 qtrs — |
| 20 | ENGINEERS GATE MANAGER LP | 12.3K +12.3K (+100.0%) | 19.7K +19.7K (+100.0%) | 0.09% +0.087 pp | 0.00% +0.000 pp | USD1.60 +0.0% | 1 qtrs NEW |
| 21 | PORTFOLIO STRATEGIES, INC. | 12.2K +12.2K (+100.0%) | 19.5K +19.5K (+100.0%) | 0.09% +0.086 pp | 0.00% +0.002 pp | USD1.60 +0.0% | 1 qtrs NEW |
| 22 | CITIGROUP INC | 12.1K +11.7K (+3,302.5%) | 19.3K +18.4K (+2,026.1%) | 0.09% +0.081 pp | 0.00% +0.000 pp | USD1.63 -1.8% | 2 qtrs — |
| 23 | IFP ADVISORS, INC | 4.4K +— (+0.0%) | 7.0K -4.2K (-37.5%) | 0.03% -0.025 pp | 0.00% 0.000 pp | USD2.56 -37.5% | 2 qtrs — |
| 24 | WELLS FARGO & COMPANY/MN | 4.3K -12.0K (-73.5%) | 6.9K -34.8K (-83.4%) | 0.03% -0.178 pp | 0.00% +0.000 pp | USD1.97 -18.8% | 4 qtrs — |
| 25 | GROUP ONE TRADING, L.P. | 3.2K +936.0 (+41.6%) | 5.1K -661.0 (-11.5%) | 0.02% -0.006 pp | 0.00% +0.000 pp | USD2.07 -22.7% | 4 qtrs — |
| 26 | CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD | 1.6K +1.6K (+100.0%) | 2.6K +2.6K (+100.0%) | 0.01% +0.012 pp | 0.00% +0.001 pp | USD1.60 +0.0% | 1 qtrs NEW |
| 27 | MORGAN STANLEY | 1.5K -177.0 (-10.8%) | 2.3K -1.9K (-44.3%) | 0.01% -0.011 pp | 0.00% +0.000 pp | USD2.05 -22.0% | 4 qtrs — |
| 28 | BANK OF AMERICA CORP /DE/ | 1.4K -5.4K (-79.0%) | 2.3K -15.3K (-86.9%) | 0.01% -0.078 pp | 0.00% +0.000 pp | USD2.44 -34.4% | 4 qtrs — |
| 29 | NEWEDGE ADVISORS, LLC | 1.3K +— (+0.0%) | 2.1K -1.3K (-37.5%) | 0.01% -0.008 pp | 0.00% +0.000 pp | USD2.55 -37.3% | 4 qtrs — |
| 30 | SBI SECURITIES CO., LTD. | 169.00 +— (+0.0%) | 270.00 -163.0 (-37.6%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD2.02 -20.8% | 4 qtrs — |
| 31 | WASHINGTON TRUST ADVISORS, INC. | 160.00 +— (+0.0%) | 256.00 -154.0 (-37.6%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD2.03 -21.2% | 4 qtrs — |
| 32 | PARKSIDE FINANCIAL BANK & TRUST | 112.00 +— (+0.0%) | 180.00 -107.0 (-37.3%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD2.03 -21.2% | 4 qtrs — |
| 33 | ANNIS GARDNER WHITING CAPITAL ADVISORS, LLC | 112.00 +112.0 (+100.0%) | 180.00 +180.0 (+100.0%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD1.60 +0.0% | 1 qtrs NEW |
| 34 | EVERSOURCE WEALTH ADVISORS, LLC | 60.00 +— (+0.0%) | 96.00 -58.0 (-37.7%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD2.55 -37.3% | 2 qtrs — |
| 35 | JPMORGAN CHASE & CO | 45.00 +— (+0.0%) | 72.00 -43.0 (-37.4%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD2.02 -20.8% | 4 qtrs — |
| 36 | FARTHER FINANCE ADVISORS, LLC | 25.00 +25.0 (+100.0%) | 40.00 +40.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.60 +0.0% | 1 qtrs NEW |
| 37 | NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 21.00 +— (+0.0%) | 34.00 -20.0 (-37.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD2.00 -20.0% | 4 qtrs — |
| 38 | BNP PARIBAS ARBITRAGE, SNC | 12.00 -27.0 (-69.2%) | 19.00 -81.0 (-81.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD2.00 -20.0% | 4 qtrs — |
| 39 | ZURCHER KANTONALBANK (ZURICH CANTONALBANK) | 2.00 -101.0 (-98.1%) | 3.00 -261.0 (-98.9%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD2.00 -20.0% | 4 qtrs — |
| 40 | US BANCORP \DE\ | 1.00 +— (+0.0%) | 2.00 -1.0 (-33.3%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD2.00 -20.0% | 4 qtrs — |
| 41 | TRIUMPH CAPITAL MANAGEMENT | 1.00 +— (+0.0%) | 2.00 -1.0 (-33.3%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD2.00 -20.0% | 2 qtrs — |
| 42 | TOWER RESEARCH CAPITAL LLC (TRC) | — -3.9K (-100.0%) | — -10.1K (-100.0%) | 0.00% -0.050 pp | 0.00% 0.000 pp | USD— | 4 qtrs SOLD |
| 43 | SLT HOLDINGS LLC | — -29.5K (-100.0%) | — -75.5K (-100.0%) | 0.00% -0.376 pp | 0.00% -0.049 pp | USD— | 2 qtrs SOLD |
| 44 | XTX TOPCO LTD | — -113.4K (-100.0%) | — -290.2K (-100.0%) | 0.00% -1.445 pp | 0.00% -0.015 pp | USD— | 3 qtrs SOLD |
| 45 | FOUNDATIONS INVESTMENT ADVISORS, LLC | — -29.5K (-100.0%) | — -75.6K (-100.0%) | 0.00% -0.377 pp | 0.00% -0.001 pp | USD— | 2 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 2 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares Micro-Cap ETF IWC | 0.00% | 72.9K | 0.60% |
| 2 | Vanguard Extended Market ETF VXF | 0.00% | 237.1K | 0.05% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
2.38
Bullish
Ratio by volume
3.00
Bullish
Buys
19
Sells
8
Shares acquired
528.6K
Shares disposed
587.00
Cash buys
—
Cash sales
—
Net activity
+528,032
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-01 | Yocca Frank | Officer | M-Exempt | A | Common Stock | 9,000 | 0.00 | — | 15,520 | D | ↗ |
| 2026-05-01 | Steinhart Richard I | Officer | M-Exempt | A | Common Stock | 9,000 | 0.00 | — | 15,645 | D | ↗ |
| 2026-05-01 | Rodriguez Javier | Officer | M-Exempt | A | Common Stock | 9,000 | 0.00 | — | 15,863 | D | ↗ |
| 2026-05-01 | Mehta Vimal | Director / Officer | M-Exempt | A | Common Stock | 18,000 | 0.00 | — | 39,259 | D | ↗ |
| 2026-03-15 | Yocca Frank | Officer | M-Exempt | D | Restricted Stock Units | 35 | 0.00 | — | 247 | D | ↗ |
| 2026-03-15 | Steinhart Richard I | Officer | M-Exempt | D | Restricted Stock Units | 35 | 0.00 | — | 247 | D | ↗ |
| 2026-03-15 | Rodriguez Javier | Officer | M-Exempt | D | Restricted Stock Units | 35 | 0.00 | — | 247 | D | ↗ |
| 2026-03-15 | Mehta Vimal | Director / Officer | M-Exempt | A | Common Stock | 219 | 0.00 | — | 21,259 | D | ↗ |
| 2026-03-14 | Yocca Frank | Officer | M-Exempt | A | Common Stock | 33 | 0.00 | — | 6,485 | D | ↗ |
| 2026-03-14 | Steinhart Richard I | Officer | M-Exempt | D | Restricted Stock Units | 33 | 0.00 | — | 97 | D | ↗ |
| 2026-03-14 | Rodriguez Javier | Officer | M-Exempt | D | Restricted Stock Units | 33 | 0.00 | — | 97 | D | ↗ |
| 2026-03-14 | Mehta Vimal | Director / Officer | M-Exempt | D | Restricted Stock Units | 164 | 0.00 | — | 488 | D | ↗ |
| 2026-01-09 | Votruba Michal | Director | A-Award | A | Stock Option (Right to Buy) | 17,000 | 2.01 | 34.2K | 17,000 | D | ↗ |
| 2026-01-09 | Patni Rajiv | Director | A-Award | A | Stock Option (Right to Buy) | 17,000 | 2.01 | 34.2K | 17,000 | D | ↗ |
| 2026-01-09 | MUELLER PETER | Director | A-Award | A | Stock Option (Right to Buy) | 17,000 | 2.01 | 34.2K | 17,000 | D | ↗ |
| 2026-01-09 | MILLER MICHAEL PATRICK | Director | A-Award | A | Stock Option (Right to Buy) | 17,000 | 2.01 | 34.2K | 17,000 | D | ↗ |
| 2026-01-09 | MACK DAVID J. | Director | A-Award | A | Stock Option (Right to Buy) | 17,000 | 2.01 | 34.2K | 17,000 | D | ↗ |
| 2026-01-09 | Laumas Sandeep | Director | A-Award | A | Stock Option (Right to Buy) | 17,000 | 2.01 | 34.2K | 17,000 | D | ↗ |
| 2026-01-09 | Bray June | Director | A-Award | A | Stock Option (Right to Buy) | 17,000 | 2.01 | 34.2K | 17,000 | D | ↗ |
| 2026-01-01 | Yocca Frank | Officer | A-Award | A | Restricted Stock Units | 70,000 | 0.00 | — | 70,282 | D | ↗ |
| 2026-01-01 | Steinhart Richard I | Officer | A-Award | A | Restricted Stock Units | 70,000 | 0.00 | — | 70,282 | D | ↗ |
| 2026-01-01 | Rodriguez Javier | Officer | A-Award | A | Restricted Stock Units | 70,000 | 0.00 | — | 70,282 | D | ↗ |
| 2026-01-01 | Mehta Vimal | Director / Officer | A-Award | A | Restricted Stock Units | 199,032 | 0.00 | — | 200,783 | D | ↗ |
| 2025-12-15 | Yocca Frank | Officer | M-Exempt | D | Restricted Stock Units | 35 | 0.00 | — | 282 | D | ↗ |
| 2025-12-15 | Steinhart Richard I | Officer | M-Exempt | D | Restricted Stock Units | 35 | 0.00 | — | 282 | D | ↗ |
| 2025-12-15 | Rodriguez Javier | Officer | M-Exempt | D | Restricted Stock Units | 35 | 0.00 | — | 282 | D | ↗ |
| 2025-12-15 | Mehta Vimal | Director / Officer | M-Exempt | A | Common Stock | 219 | 0.00 | — | 20,876 | D | ↗ |
| 2025-12-14 | Yocca Frank | Officer | M-Exempt | A | Common Stock | 33 | 0.00 | — | 6,417 | D | ↗ |
| 2025-12-14 | Steinhart Richard I | Officer | M-Exempt | A | Common Stock | 33 | 0.00 | — | 6,542 | D | ↗ |
| 2025-12-14 | Rodriguez Javier | Officer | M-Exempt | A | Common Stock | 33 | 0.00 | — | 6,760 | D | ↗ |
| 2025-12-14 | Mehta Vimal | Director / Officer | M-Exempt | D | Restricted Stock Units | 164 | 0.00 | — | 652 | D | ↗ |
| 2025-10-31 | MACK DAVID J. | Director | M-Exempt | A | Common Stock | 1,694 | 0.00 | — | 20,317 | D | ↗ |
| 2025-09-30 | MACK DAVID J. | Director | M-Exempt | A | Common Stock | 1,694 | 0.00 | — | 18,623 | D | ↗ |
| 2025-09-15 | Yocca Frank | Officer | M-Exempt | A | Common Stock | 35 | 0.00 | — | 6,384 | D | ↗ |
| 2025-09-15 | Steinhart Richard I | Officer | M-Exempt | D | Restricted Stock Units | 35 | 0.00 | — | 317 | D | ↗ |
| 2025-09-15 | Rodriguez Javier | Officer | M-Exempt | D | Restricted Stock Units | 35 | 0.00 | — | 317 | D | ↗ |
| 2025-09-15 | Mehta Vimal | Director / Officer | M-Exempt | A | Common Stock | 219 | 0.00 | — | 20,493 | D | ↗ |
| 2025-09-14 | Yocca Frank | Officer | M-Exempt | A | Common Stock | 33 | 0.00 | — | 6,349 | D | ↗ |
| 2025-09-14 | Steinhart Richard I | Officer | M-Exempt | A | Common Stock | 33 | 0.00 | — | 6,474 | D | ↗ |
| 2025-09-14 | Rodriguez Javier | Officer | M-Exempt | A | Common Stock | 33 | 0.00 | — | 6,692 | D | ↗ |
| 2025-09-14 | Mehta Vimal | Director / Officer | M-Exempt | D | Restricted Stock Units | 163 | 0.00 | — | 816 | D | ↗ |
| 2025-08-31 | MACK DAVID J. | Director | M-Exempt | D | Restricted Stock Units | 1,693 | 0.00 | — | 3,387 | D | ↗ |
| 2025-08-01 | Yocca Frank | Officer | A-Award | A | Restricted Stock Units | 9,000 | 0.00 | — | 9,000 | D | ↗ |
| 2025-08-01 | Steinhart Richard I | Officer | A-Award | A | Restricted Stock Units | 9,000 | 0.00 | — | 9,000 | D | ↗ |
| 2025-08-01 | Rodriguez Javier | Officer | A-Award | A | Restricted Stock Units | 9,000 | 0.00 | — | 9,000 | D | ↗ |
| 2025-08-01 | Mehta Vimal | Director / Officer | A-Award | A | Restricted Stock Units | 18,000 | 0.00 | — | 18,000 | D | ↗ |
| 2025-07-31 | MACK DAVID J. | Director | M-Exempt | A | Common Stock | 1,693 | 0.00 | — | 15,237 | D | ↗ |
| 2025-07-22 | Yocca Frank | Officer | A-Award | A | Common Stock | 4,375 | 0.00 | — | 6,316 | D | ↗ |
| 2025-07-22 | Steinhart Richard I | Officer | M-Exempt | D | Restricted Stock Units | 625 | 0.00 | — | 0 | D | ↗ |
| 2025-07-22 | Rodriguez Javier | Officer | A-Award | A | Common Stock | 4,375 | 0.00 | — | 6,034 | D | ↗ |
| 2025-07-22 | Mehta Vimal | Director / Officer | A-Award | A | Common Stock | 15,625 | 0.00 | — | 20,111 | D | ↗ |
| 2025-06-30 | MACK DAVID J. | Director | M-Exempt | A | Common Stock | 1,693 | 0.00 | — | 13,544 | D | ↗ |
| 2025-06-15 | Yocca Frank | Officer | M-Exempt | D | Restricted Stock Units | 35 | 0.00 | — | 352 | D | ↗ |
| 2025-06-15 | Steinhart Richard I | Officer | M-Exempt | A | Common Stock | 35 | 0.00 | — | 1,441 | D | ↗ |
| 2025-06-15 | Rodriguez Javier | Officer | M-Exempt | D | Restricted Stock Units | 35 | 0.00 | — | 352 | D | ↗ |
| 2025-06-15 | Mehta Vimal | Director / Officer | M-Exempt | D | Restricted Stock Units | 219 | 0.00 | — | 2,189 | D | ↗ |
| 2025-06-14 | Yocca Frank | Officer | M-Exempt | D | Restricted Stock Units | 33 | 0.00 | — | 196 | D | ↗ |
| 2025-06-14 | Steinhart Richard I | Officer | M-Exempt | D | Restricted Stock Units | 33 | 0.00 | — | 196 | D | ↗ |
| 2025-06-14 | Rodriguez Javier | Officer | M-Exempt | D | Restricted Stock Units | 33 | 0.00 | — | 196 | D | ↗ |
| 2025-06-14 | Mehta Vimal | Director / Officer | M-Exempt | D | Restricted Stock Units | 163 | 0.00 | — | 979 | D | ↗ |
| 2025-05-31 | MACK DAVID J. | Director | M-Exempt | A | Common Stock | 1,693 | 0.00 | — | 11,851 | D | ↗ |
| 2025-04-30 | MACK DAVID J. | Director | M-Exempt | A | Common Stock | 1,693 | 0.00 | — | 10,158 | D | ↗ |
| 2025-03-31 | MACK DAVID J. | Director | M-Exempt | D | Restricted Stock Units | 1,693 | 0.00 | — | 11,852 | D | ↗ |
| 2025-03-15 | Yocca Frank | Officer | M-Exempt | D | Restricted Stock Units | 34 | 0.00 | — | 387 | D | ↗ |
| 2025-03-15 | Steinhart Richard I | Officer | M-Exempt | A | Common Stock | 34 | 0.00 | — | 1,373 | D | ↗ |
| 2025-03-15 | Rodriguez Javier | Officer | M-Exempt | A | Common Stock | 34 | 0.00 | — | 1,591 | D | ↗ |
| 2025-03-15 | Mehta Vimal | Director / Officer | M-Exempt | D | Restricted Stock Units | 217 | 0.00 | — | 2,408 | D | ↗ |
| 2025-03-14 | Yocca Frank | Officer | M-Exempt | D | Restricted Stock Units | 31 | 0.00 | — | 229 | D | ↗ |
| 2025-03-14 | Steinhart Richard I | Officer | M-Exempt | A | Common Stock | 31 | 0.00 | — | 1,339 | D | ↗ |
| 2025-03-14 | Rodriguez Javier | Officer | M-Exempt | D | Restricted Stock Units | 31 | 0.00 | — | 229 | D | ↗ |
| 2025-03-14 | Mehta Vimal | Director / Officer | M-Exempt | D | Restricted Stock Units | 162 | 0.00 | — | 1,142 | D | ↗ |
| 2025-02-28 | MACK DAVID J. | Director | M-Exempt | D | Restricted Stock Units | 1,693 | 0.00 | — | 13,545 | D | ↗ |
| 2025-01-31 | MACK DAVID J. | Director | M-Exempt | D | Restricted Stock Units | 27,089 | 0.00 | — | 243,810 | D | ↗ |
| 2025-01-15 | Patni Rajiv | Director | A-Award | A | Stock Option (right to buy) | 44,000 | 0.35 | 15.2K | 44,000 | D | ↗ |
| 2025-01-07 | Yocca Frank | Officer | A-Award | A | Stock Option (right to buy) | 270,000 | 0.47 | 127.3K | 270,000 | D | ↗ |
| 2025-01-07 | Steinhart Richard I | Officer | A-Award | A | Stock Option (right to buy) | 270,000 | 0.47 | 127.3K | 270,000 | D | ↗ |
| 2025-01-07 | Mehta Vimal | Director / Officer / 10% Owner | A-Award | A | Stock Option (right to buy) | 660,000 | 0.47 | 311.1K | 660,000 | D | ↗ |
| 2024-12-31 | MACK DAVID J. | Director | M-Exempt | A | Restricted Stock Units | 27,089 | 0.00 | — | 270,899 | D | ↗ |
| 2024-12-16 | Yocca Frank | Officer | S-Sale | D | Common Stock | 205 | 0.36 | 72.80 | 29,156 | D | ↗ |
| 2024-12-16 | Steinhart Richard I | Officer | S-Sale | D | Common Stock | 205 | 0.36 | 73.80 | 21,157 | D | ↗ |
| 2024-12-16 | O'Neill Vincent | Officer | S-Sale | D | Common Stock | 165 | 0.35 | 58.13 | 19,957 | D | ↗ |
| 2024-12-16 | Mehta Vimal | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 2,134 | 0.36 | 773.36 | 59,605 | D | ↗ |
| 2024-12-15 | Yocca Frank | Officer | M-Exempt | D | Restricted Stock Units | 562 | 0.00 | — | 5,064 | D | ↗ |
| 2024-12-15 | Steinhart Richard I | Officer | M-Exempt | D | Restricted Stock Units | 562 | 0.00 | — | 5,064 | D | ↗ |
| 2024-12-15 | Mehta Vimal | Director / Officer / 10% Owner | M-Exempt | A | Common Stock | 3,500 | 0.00 | — | 61,903 | D | ↗ |
| 2024-12-14 | Yocca Frank | Officer | M-Exempt | A | Common Stock | 521 | 0.00 | — | 28,799 | D | ↗ |
| 2024-12-14 | Steinhart Richard I | Officer | M-Exempt | A | Common Stock | 521 | 0.00 | — | 20,800 | D | ↗ |
| 2024-12-14 | O'Neill Vincent | Officer | M-Exempt | D | Restricted Stock Units | 521 | 0.00 | — | 2,606 | D | ↗ |
| 2024-12-14 | Mehta Vimal | Director / Officer / 10% Owner | M-Exempt | D | Restricted Stock Units | 2,610 | 0.00 | — | 13,049 | D | ↗ |
| 2024-11-30 | MACK DAVID J. | Director | M-Exempt | D | Restricted Stock Units | 27,089 | 0.00 | — | 297,988 | D | ↗ |
| 2024-11-21 | MACK DAVID J. | Director | A-Award | A | Restricted Stock Units | 325,077 | 0.00 | — | 325,077 | D | ↗ |
| 2024-10-03 | Yocca Frank | Officer | S-Sale | D | Common Stock | 7,175 | 0.55 | 3.9K | 28,278 | D | ↗ |
| 2024-10-03 | Wiley Matthew T. | Officer | S-Sale | D | Common Stock | 6,272 | 0.55 | 3.4K | 19,011 | D | ↗ |
| 2024-10-03 | Steinhart Richard I | Officer | S-Sale | D | Common Stock | 7,175 | 0.55 | 3.9K | 20,279 | D | ↗ |
| 2024-10-03 | Rodriguez Javier | Officer | S-Sale | D | Common Stock | 6,863 | 0.55 | 3.8K | 23,770 | D | ↗ |
| 2024-10-03 | O'Neill Vincent | Officer | S-Sale | D | Common Stock | 5,556 | 0.55 | 3.1K | 19,601 | D | ↗ |
| 2024-09-17 | Yocca Frank | Officer | A-Award | A | Common Stock | 21,250 | 0.00 | — | 35,453 | D | ↗ |
| 2024-09-17 | Wiley Matthew T. | Officer | A-Award | A | Common Stock | 21,250 | 0.00 | — | 25,283 | D | ↗ |
| 2024-09-17 | Steinhart Richard I | Officer | A-Award | A | Common Stock | 21,250 | 0.00 | — | 27,454 | D | ↗ |
| 2024-09-17 | Rodriguez Javier | Officer | A-Award | A | Common Stock | 21,250 | 0.00 | — | 30,633 | D | ↗ |
| 2024-09-17 | O'Neill Vincent | Officer | A-Award | A | Common Stock | 21,250 | 0.00 | — | 25,157 | D | ↗ |
| 2024-09-16 | Yocca Frank | Officer | S-Sale | D | Common Stock | 355 | 0.69 | 244.70 | 14,203 | — | ↗ |
| 2024-09-16 | Wiley Matthew T. | Officer | S-Sale | D | Common Stock | 215 | 0.69 | 148.52 | 4,033 | — | ↗ |
| 2024-09-16 | Steinhart Richard I | Officer | S-Sale | D | Common Stock | 356 | 0.69 | 245.60 | 6,204 | — | ↗ |
| 2024-09-16 | Rodriguez Javier | Officer | S-Sale | D | Common Stock | 345 | 0.69 | 238.05 | 9,133 | — | ↗ |
| 2024-09-16 | O'Neill Vincent | Officer | S-Sale | D | Common Stock | 138 | 0.69 | 95.33 | 3,907 | — | ↗ |
| 2024-09-16 | Mehta Vimal | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 1,150 | 0.69 | 794.08 | 51,666 | — | ↗ |
| 2024-09-15 | Yocca Frank | Officer | M-Exempt | D | Restricted Stock Units | 563 | 0.00 | — | 5,625 | — | ↗ |
| 2024-09-15 | Wiley Matthew T. | Officer | M-Exempt | A | Common Stock | 750 | 0.00 | — | 4,248 | — | ↗ |
| 2024-09-15 | Steinhart Richard I | Officer | M-Exempt | D | Restricted Stock Units | 563 | 0.00 | — | 5,625 | — | ↗ |
| 2024-09-15 | Rodriguez Javier | Officer | M-Exempt | D | Restricted Stock Units | 563 | 0.00 | — | 5,625 | — | ↗ |
| 2024-09-15 | Mehta Vimal | Director / Officer / 10% Owner | M-Exempt | A | Common Stock | 3,500 | 0.00 | — | 53,648 | — | ↗ |
| 2024-09-14 | Yocca Frank | Officer | M-Exempt | D | Restricted Stock Units | 521 | 0.00 | — | 3,127 | — | ↗ |
| 2024-09-14 | Steinhart Richard I | Officer | M-Exempt | A | Common Stock | 521 | 0.00 | — | 5,997 | — | ↗ |
| 2024-09-14 | Rodriguez Javier | Officer | M-Exempt | D | Restricted Stock Units | 521 | 0.00 | — | 3,127 | — | ↗ |
| 2024-09-14 | O'Neill Vincent | Officer | M-Exempt | A | Common Stock | 521 | 0.00 | — | 4,045 | — | ↗ |
| 2024-09-14 | Mehta Vimal | Director / Officer / 10% Owner | M-Exempt | D | Restricted Stock Units | 2,609 | 0.00 | — | 15,657 | — | ↗ |
| 2024-07-22 | Yocca Frank | Officer | A-Award | A | Stock Option (right to buy) | 1,875 | 1.20 | 2.3K | 1,875 | D | ↗ |
| 2024-07-22 | Wiley Matthew T. | Other | A-Award | A | Stock Option (right to buy) | 1,875 | 1.20 | 2.3K | 1,875 | D | ↗ |
| 2024-07-22 | Steinhart Richard I | Officer | A-Award | A | Stock Option (right to buy) | 1,875 | 1.20 | 2.3K | 1,875 | D | ↗ |
| 2024-07-22 | Rodriguez Javier | Officer | A-Award | A | Restricted Stock Units | 625 | 0.00 | — | 625 | D | ↗ |
| 2024-07-22 | O'Neill Vincent | Other | A-Award | A | Stock Option (right to buy) | 1,875 | 1.20 | 2.3K | 1,875 | D | ↗ |
| 2024-07-22 | Mehta Vimal | Director / Officer | A-Award | A | Stock Option (right to buy) | 6,250 | 1.20 | 7.5K | 6,250 | D | ↗ |
| 2024-06-17 | Yocca Frank | Officer | S-Sale | D | Common Stock | 372 | 1.28 | 476.16 | 13,474 | — | ↗ |
| 2024-06-17 | Wiley Matthew T. | Officer | S-Sale | D | Common Stock | 244 | 1.26 | 308.10 | 3,498 | — | ↗ |
| 2024-06-17 | Steinhart Richard I | Officer | S-Sale | D | Common Stock | 372 | 1.26 | 469.54 | 5,476 | — | ↗ |
| 2024-06-17 | Rodriguez Javier | Officer | S-Sale | D | Common Stock | 361 | 1.26 | 456.02 | 8,394 | — | ↗ |
| 2024-06-17 | O'Neill Vincent | Officer | S-Sale | D | Common Stock | 155 | 1.29 | 199.18 | 3,524 | — | ↗ |
| 2024-06-17 | Mehta Vimal | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 2,134 | 1.28 | 2.7K | 47,539 | — | ↗ |
| 2024-06-15 | Yocca Frank | Officer | M-Exempt | D | Restricted Stock Units | 562 | 0.00 | — | 6,188 | — | ↗ |
| 2024-06-15 | Wiley Matthew T. | Officer | M-Exempt | A | Restricted Stock Units | 750 | 0.00 | — | 8,250 | — | ↗ |
| 2024-06-15 | Steinhart Richard I | Officer | M-Exempt | A | Common Stock | 562 | 0.00 | — | 5,848 | — | ↗ |
| 2024-06-15 | Rodriguez Javier | Officer | M-Exempt | D | Restricted Stock Units | 562 | 0.00 | — | 6,188 | — | ↗ |
| 2024-06-15 | Mehta Vimal | Director / Officer / 10% Owner | M-Exempt | A | Common Stock | 3,500 | 0.00 | — | 49,673 | — | ↗ |
| 2024-06-14 | Yocca Frank | Officer | M-Exempt | D | Restricted Stock Units | 521 | 0.00 | — | 3,648 | — | ↗ |
| 2024-06-14 | Steinhart Richard I | Officer | M-Exempt | D | Restricted Stock Units | 521 | 0.00 | — | 3,648 | — | ↗ |
| 2024-06-14 | Rodriguez Javier | Officer | M-Exempt | A | Common Stock | 521 | 0.00 | — | 8,193 | — | ↗ |
| 2024-06-14 | O'Neill Vincent | Officer | M-Exempt | D | Restricted Stock Units | 521 | 0.00 | — | 3,648 | — | ↗ |
| 2024-06-14 | Mehta Vimal | Director / Officer / 10% Owner | M-Exempt | A | Common Stock | 2,609 | 0.00 | — | 46,173 | — | ↗ |
| 2024-06-10 | Votruba Michal | Director | A-Award | A | Stock Option (Right to Buy) | 17,000 | 1.44 | 24.5K | 17,000 | — | ↗ |
| 2024-06-10 | MUELLER PETER | Director | A-Award | A | Stock Option (Right to Buy) | 17,000 | 1.44 | 24.5K | 17,000 | — | ↗ |
| 2024-06-10 | MILLER MICHAEL PATRICK | Director | A-Award | A | Stock Option (Right to Buy) | 17,000 | 1.44 | 24.5K | 17,000 | — | ↗ |
| 2024-06-10 | Laumas Sandeep | Director | A-Award | A | Stock Option (Right to Buy) | 17,000 | 1.44 | 24.5K | 17,000 | — | ↗ |
| 2024-06-10 | Bray June | Director | A-Award | A | Stock Option (Right to Buy) | 17,000 | 1.44 | 24.5K | 17,000 | — | ↗ |
| 2024-06-05 | Mehta Vimal | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 283,122 | 0.00 | — | 0 | — | ↗ |
| 2024-06-04 | Mehta Vimal | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 126,014 | 1.63 | 205.5K | 7,811,515 | — | ↗ |
| 2024-04-04 | Yocca Frank | Officer | S-Sale | D | Common Stock | 1,067 | 2.64 | 2.8K | 12,763 | — | ↗ |
| 2024-04-04 | Wiley Matthew T. | Officer | S-Sale | D | Common Stock | 1,008 | 2.64 | 2.7K | 2,992 | — | ↗ |
| 2024-04-04 | Steinhart Richard I | Officer | S-Sale | D | Common Stock | 1,069 | 2.64 | 2.8K | 4,765 | — | ↗ |
| 2024-04-04 | Rodriguez Javier | Officer | S-Sale | D | Common Stock | 1,012 | 2.64 | 2.7K | 7,672 | — | ↗ |
| 2024-04-04 | O'Neill Vincent | Officer | S-Sale | D | Common Stock | 165 | 2.62 | 432.48 | 5,408 | — | ↗ |
| 2024-04-04 | Mehta Vimal | Director / Officer | S-Sale | D | Common Stock | 4,439 | 2.62 | 11.7K | 43,564 | — | ↗ |
| 2024-03-15 | Yocca Frank | Officer | M-Exempt | A | Common Stock | 2,250 | 0.00 | — | 13,830 | — | ↗ |
| 2024-03-15 | Wiley Matthew T. | Officer | M-Exempt | A | Restricted Stock Units | 3,000 | 0.00 | — | 9,000 | — | ↗ |
| 2024-03-15 | Steinhart Richard I | Officer | M-Exempt | A | Common Stock | 2,250 | 0.00 | — | 5,834 | — | ↗ |
| 2024-03-15 | Rodriguez Javier | Officer | M-Exempt | A | Common Stock | 2,250 | 0.00 | — | 8,684 | — | ↗ |
| 2024-03-15 | O'Neill Vincent | Officer | M-Exempt | D | Restricted Stock Units | 2,250 | 0.00 | — | 6,750 | — | ↗ |
| 2024-03-15 | Mehta Vimal | Director / Officer | M-Exempt | D | Restricted Stock Units | 14,000 | 0.00 | — | 42,000 | — | ↗ |
| 2024-03-14 | Yocca Frank | Officer | M-Exempt | D | Restricted Stock Units | 521 | 0.00 | — | 4,169 | — | ↗ |
| 2024-03-14 | Steinhart Richard I | Officer | M-Exempt | D | Restricted Stock Units | 521 | 0.00 | — | 4,169 | — | ↗ |
| 2024-03-14 | Rodriguez Javier | Officer | M-Exempt | A | Common Stock | 521 | 0.00 | — | 6,434 | — | ↗ |
| 2024-03-14 | O'Neill Vincent | Officer | M-Exempt | D | Restricted Stock Units | 521 | 0.00 | — | 4,169 | — | ↗ |
| 2024-03-14 | Mehta Vimal | Director / Officer | M-Exempt | A | Common Stock | 2,610 | 0.00 | — | 34,832 | — | ↗ |
| 2023-12-14 | Yocca Frank | Officer | M-Exempt | D | Restricted Stock Units | 521 | 0.00 | — | 4,690 | — | ↗ |
| 2023-12-14 | Steinhart Richard I | Officer | M-Exempt | A | Common Stock | 521 | 0.00 | — | 3,063 | — | ↗ |
| 2023-12-14 | Rodriguez Javier | Officer | M-Exempt | D | Restricted Stock Units | 521 | 0.00 | — | 4,690 | — | ↗ |
| 2023-12-14 | O'Neill Vincent | Officer | M-Exempt | A | Common Stock | 521 | 0.00 | — | 2,802 | — | ↗ |
| 2023-12-14 | Mehta Vimal | Director / Officer | M-Exempt | D | Restricted Stock Units | 2,609 | 0.00 | — | 23,485 | — | ↗ |
| 2023-09-14 | Yocca Frank | Officer | M-Exempt | D | Restricted Stock Units | 521 | 0.00 | — | 5,211 | — | ↗ |
| 2023-09-14 | Steinhart Richard I | Officer | M-Exempt | A | Common Stock | 521 | 0.00 | — | 2,542 | — | ↗ |
| 2023-09-14 | Rodriguez Javier | Officer | M-Exempt | D | Restricted Stock Units | 521 | 0.00 | — | 5,211 | — | ↗ |
| 2023-09-14 | O'Neill Vincent | Officer | M-Exempt | A | Common Stock | 521 | 0.00 | — | 2,281 | — | ↗ |
| 2023-09-14 | Mehta Vimal | Director / Officer | M-Exempt | D | Restricted Stock Units | 2,610 | 0.00 | — | 26,094 | — | ↗ |
| 2023-06-26 | Votruba Michal | Director | A-Award | A | Stock Option (Right to Buy) | 17,000 | 17.52 | 297.8K | 17,000 | — | ↗ |
| 2023-06-26 | MUELLER PETER | Director | A-Award | A | Stock Option (Right to Buy) | 17,000 | 17.52 | 297.8K | 17,000 | — | ↗ |
| 2023-06-26 | MILLER MICHAEL PATRICK | Director | A-Award | A | Stock Option (Right to Buy) | 17,000 | 17.52 | 297.8K | 17,000 | — | ↗ |
| 2023-06-26 | Laumas Sandeep | Director | A-Award | A | Stock Option (Right to Buy) | 17,000 | 17.52 | 297.8K | 17,000 | — | ↗ |
| 2023-06-26 | Bray June | Director | A-Award | A | Stock Option (Right to Buy) | 17,000 | 17.52 | 297.8K | 17,000 | — | ↗ |
| 2023-06-16 | Mehta Vimal | Director / Officer | S-Sale | D | Common Stock | 4,266 | 20.90 | 89.2K | 40,650 | — | ↗ |
| 2023-06-15 | Mehta Vimal | Director / Officer | S-Sale | D | Common Stock | 8,012 | 21.90 | 175.5K | 39,903 | — | ↗ |
| 2023-06-14 | Yocca Frank | Officer | M-Exempt | D | Restricted Stock Units | 521 | 0.00 | — | 5,732 | — | ↗ |
| 2023-06-14 | Steinhart Richard I | Officer | M-Exempt | A | Common Stock | 521 | 0.00 | — | 2,021 | — | ↗ |
| 2023-06-14 | Rodriguez Javier | Officer | M-Exempt | D | Restricted Stock Units | 521 | 0.00 | — | 5,732 | — | ↗ |
| 2023-06-14 | O'Neill Vincent | Officer | M-Exempt | A | Common Stock | 521 | 0.00 | — | 1,760 | — | ↗ |
| 2023-06-14 | Mehta Vimal | Director / Officer | M-Exempt | D | Restricted Stock Units | 2,609 | 0.00 | — | 28,704 | — | ↗ |
| 2023-05-22 | Mehta Vimal | Director / Officer | S-Sale | D | Common Stock | 6,500 | 25.79 | 167.6K | 37,294 | — | ↗ |
| 2023-05-15 | Steinhart Richard I | Officer | S-Sale | D | Common Stock | 5,000 | 27.17 | 135.9K | 1,500 | — | ↗ |
| 2023-05-15 | Rodriguez Javier | Officer | S-Sale | D | Common Stock | 1,785 | 27.32 | 48.8K | 4,350 | — | ↗ |
| 2023-05-14 | Steinhart Richard I | Officer | M-Exempt | D | Restricted Stock Units | 5,000 | 0.00 | — | 0 | — | ↗ |
| 2023-05-14 | Rodriguez Javier | Officer | M-Exempt | D | Restricted Stock Units | 5,000 | 0.00 | — | 0 | — | ↗ |
| 2023-05-14 | Mehta Vimal | Officer | M-Exempt | D | Restricted Stock Units | 15,000 | 0.00 | — | 0 | — | ↗ |
| 2023-04-06 | Nandabalan Krishnan | Director / 10% Owner | S-Sale | D | Common Stock | 60,000 | 17.32 | 1.04M | 0 | — | ↗ |
| 2023-04-03 | Sood Pardeep Kumar | 10% Owner | — | I | Common Stock, par value $0.001 per share | 0 | 0.00 | — | 8,546,750 | — | ↗ |
| 2023-04-03 | Sood Alka | 10% Owner | — | I | Common Stock, par value $0.001 per share | 0 | 0.00 | — | 8,546,750 | — | ↗ |
| 2023-04-03 | Patel Krunal Dilip | 10% Owner | — | I | Common Stock, par value $0.001 per share | 0 | 0.00 | — | 8,546,750 | — | ↗ |
| 2023-04-03 | Patel Jatin Markand | 10% Owner | — | I | Common Stock, par value $0.001 per share | 0 | 0.00 | — | 8,546,750 | — | ↗ |
| 2023-04-03 | Patel Bina Jatin | 10% Owner | — | I | Common Stock, par value $0.001 per share | 0 | 0.00 | — | 8,546,750 | — | ↗ |
| 2023-04-03 | Jain Diwakar | 10% Owner | — | D | Common Stock, par value $0.001 per share | 0 | 0.00 | — | 550 | — | ↗ |
| 2023-04-03 | Jain Anita | 10% Owner | — | I | Common Stock, par value $0.001 per share | 0 | 0.00 | — | 8,546,750 | — | ↗ |
| 2023-04-03 | Gupta Tarun K. | 10% Owner | — | I | Common Stock, par value $0.001 per share | 0 | 0.00 | — | 8,546,750 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-13.4K
Shares Outstanding
27.07M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2024 | Vimal Mehta, Ph.D. Chief Executive Officer | 1.00M | — | — | 101.3K | — | 16.4K | 1.12M | 9.05% | ↗ |
| 2 | 2024 | Javier Rodriguez Senior VP and Chief Legal Officer | 423.8K | — | 181.8K | 398.5K | — | 8.6K | 1.01M | 57.31% | ↗ |
| 3 | 2024 | Richard Steinhart SVP and Chief Financial Officer | 409.9K | — | 181.8K | 398.3K | — | 4.1K | 998.2K | 58.11% | ↗ |
| 4 | 2023 | Vimal Mehta, Ph.D. Chief Executive Officer | 1.00M | — | 1.10M | 2.62M | — | 16.1K | 4.73M | 78.49% | ↗ |
| 5 | 2023 | Matthew Wiley SVP and Chief Commercial Officer | 445.2K | — | 250.4K | 560.6K | — | 8.3K | 1.26M | 64.14% | ↗ |
| 6 | 2023 | Javier Rodriguez Senior VP and Chief Legal Officer | 423.8K | — | 191.6K | 498.3K | — | 8.3K | 1.12M | 61.49% | ↗ |
| 7 | 2022 | Vimal Mehta, Ph.D. Chief Executive Officer | 944.4K | 150.0K | 800.6K | 1.99M | 654.7K | 15.4K | 4.56M | 61.30% | ↗ |
| 8 | 2022 | Matthew Wiley SVP and Chief Commercial Officer | 402.5K | — | — | 1.31M | 210.0K | 7.6K | 1.93M | 67.83% | ↗ |
| 9 | 2022 | Javier Rodriguez Senior VP and Chief Legal Officer | 403.7K | 50.0K | 181.4K | 398.2K | 177.6K | 7.6K | 1.22M | 47.57% | ↗ |
| 10 | 2021 | Vimal Mehta, Ph.D. Chief Executive Officer | 916.7K | — | — | 7.96M | 483.1K | 7.8K | 9.37M | 84.98% | ↗ |
| 11 | 2021 | Vimal Mehta, Ph.D. Chief Executive Officer and President | 916.7K | — | — | 7.96M | 483.1K | 7.8K | 9.37M | 84.98% | ↗ |
| 12 | 2021 | Javier Rodriquez Senior Vice President and Chief Legal Officer | 334.0K | — | — | 1.54M | 136.5K | — | 2.01M | 76.64% | ↗ |
| 13 | 2021 | Javier Rodriguez Senior VP and Chief Legal Officer | 334.0K | — | — | 1.54M | 136.5K | — | 2.01M | 76.64% | ↗ |
| 14 | 2021 | Frank Yocca Senior Vice President and Chief Scientific Officer | 333.3K | — | — | 700.9K | 112.9K | 6.4K | 1.15M | 60.76% | ↗ |
| 15 | 2020 | Vimal Mehta, Ph.D. Chief Executive Officer and President | 890.0K | — | — | 8.12M | 556.3K | 7.8K | 9.58M | 84.82% | ↗ |
| 16 | 2020 | William P. Kane, Jr. Executive Vice President and Chief Commercial Officer | 245.5K | — | — | 4.19M | 138.7K | — | 4.57M | 91.59% | ↗ |
| 17 | 2020 | Reina Benabou, M.D., Ph.D. Senior Vice President and Chief Development Officer | 197.4K | — | — | 2.46M | 76.3K | — | 2.74M | 89.99% | ↗ |
| 18 | 2019 | Vimal Mehta, Ph.D. Chief Executive Officer and President | 459.0K | — | — | 1.27M | 233.0K | 7.8K | 1.97M | 64.46% | ↗ |
| 19 | 2019 | Vimal Mehta, Ph.D. President and Chief Executive Officer | 459.0K | — | — | 1.27M | 233.0K | 7.8K | 1.97M | 64.46% | ↗ |
| 20 | 2019 | Vincent O’Neill, M.D. Chief Medical Officer | 406.2K | — | — | — | 102.8K | 1.2K | 510.2K | 0.00% | ↗ |
| 21 | 2019 | Richard Steinhart Chief Financial Officer | 285.6K | — | — | — | 114.1K | 4.3K | 404.0K | 0.00% | ↗ |
| 22 | 2018 | Vimal Mehta President and Chief Executive Officer | 423.4K | 270.0K | — | — | — | 8.3K | 701.6K | 0.00% | ↗ |
| 23 | 2018 | Vimal Mehta, Ph.D. President and Chief Executive Officer | 423.4K | 270.0K | — | — | — | 8.3K | 701.6K | 0.00% | ↗ |
| 24 | 2018 | Vincent O'Neill Senior Vice President and Chief Medical Officer | 336.9K | 65.7K | — | 260.2K | — | 502.00 | 663.3K | 39.23% | ↗ |
| 25 | 2018 | Vincent O’Neill, M.D. Chief Medical Officer | 336.9K | 65.7K | — | 260.2K | — | 502.00 | 663.3K | 39.23% | ↗ |
| 26 | 2018 | Frank Yocca, Ph.D. Senior Vice President and Chief Scientific Officer | 296.9K | 93.4K | — | 260.9K | — | 3.3K | 654.4K | 39.87% | ↗ |
| 27 | 2017 | Vimal Mehta President and Chief Executive Officer | 147.0K | — | — | 125.9K | — | 10.6K | 283.5K | 44.42% | ↗ |
| 28 | 2017 | Frank Yocca, Ph.D. Senior Vice President and Chief Scientific Officer | 168.0K | — | — | 42.0K | — | — | 210.0K | 20.00% | ↗ |
| 29 | 2017 | Vincent O'Neill Senior Vice President and Chief Medical Officer | 49.5K | — | — | 41.1K | — | — | 90.6K | 45.34% | ↗ |
CEO compensation breakdown
Proxy statements
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Vimal D. Mehta | Founder, Chief Executive Officer, President, & Director | 715.3K | — |
| Frank D. Yocca | Executive Vice President & Chief Scientific Officer | 452.6K | — |
| Javier Rodriguez | Senior Vice President, Chief Legal Officer & Corporate Secretary | 432.6K | male |
| Richard I. Steinhart | Senior Vice President & Chief Financial Officer | 289.8K | male |
| Mark Pavao | Acting Chief Commercial Officer | — | male |
| Matt Mandel | Vice President of Clinical Development | — | male |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for BTAI
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
